CIK 0001652130 · Large accelerated filer
Intellia Therapeutics, Inc.
Sign in to watch- Ticker
- NTLA
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364785571
- Phone
- 857-285-6200
- Business address
- 400 TECHNOLOGY SQUARE, SUITE 100, CAMBRIDGE, MA
- POSASR Other POSASR
- S-3ASR Offering Registration Statement
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- CT ORDER Other Confidential Order
- CT ORDER Other Confidential Order
- S-8 Other Securities Offered to Employees in Benefit Plans
- CT ORDER Other Confidential Order
- CERTNAS Other Certification by the Nasdaq Stock Market
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- 8-A12B Other Registration of Securities
- FWP Offering Free Writing Prospectus
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS/A Other Draft Registration Statement
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
Page 3 of 3 · 58 filings